Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Study of E6005 in Pediatric Atopic Dermatitis
jRCT2080222693Phase 2
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in atopic dermatitis (AD) comparing E6005 arm with Placebo arm (2 arms).
02
Drugs
lotamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080222693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222693.